In this issue:
Biologics extend survival in metastatic CRC regardless of race
Increasing alcohol tax mitigates cancer rates and mortality in the EU
MG1 efficacious for treatment of OIPN
Cost and utilisation of cancer drugs without proven survival benefit in the US
Laparoscopy useful for staging of locally advanced gastric cancer
Chemotherapy improves survival in resectable gastric cancer
Cancer patients undergoing therapy mount a robust COVID-19 vaccination response
NETTER-1: No survival benefit to 177Lu-Dotatate for midgut NETs
Addition of anti-EGFR antibody to maintenance beneficial for metastatic CRC
Adjuvant chemotherapy extends DFS in liver-only metastatic CRC
Please login below to download this issue (PDF)